Parnell Pharmaceuticals Holdings Price to Book Ratio 2014-2018 | PARNF
Historical price to book ratio values for Parnell Pharmaceuticals Holdings (PARNF) over the last 10 years. The current price to book ratio for Parnell Pharmaceuticals Holdings as of June 05, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Parnell Pharmaceuticals Holdings Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2025-04-22 |
0.08 |
|
0.00 |
| 2018-03-31 |
0.30 |
|
0.00 |
| 2017-12-31 |
0.60 |
|
0.00 |
| 2016-12-31 |
0.69 |
|
0.00 |
| 2016-09-30 |
1.42 |
|
0.00 |
| 2015-12-31 |
3.88 |
|
0.00 |
| 2015-09-30 |
3.44 |
|
0.00 |
| 2015-06-30 |
4.95 |
|
0.00 |
| 2015-03-31 |
4.91 |
|
0.00 |
| 2014-12-31 |
4.15 |
|
0.00 |
| 2014-09-30 |
5.75 |
|
0.00 |
| 2014-06-30 |
6.90 |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
